Acerus Pharmaceuticals Corporation (ASP) Fundamentals

Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.
SHARE INFORMATION
Market Cap$ 22 659 315
Shares Outstanding7 707 747
Float-
Percent Float0,0%
Short Interest259,00
Short Percent Float100,0%
Short Interest Ratio0,318966
Short Interest Date2022-06-15
Latest Fiscal Dividend Per Share$ 0,00
Latest Fiscal Revenue$ -5 223 760
Latest Fiscal EPS$ -5,06
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0,00
Dividend (5 Years)$ 0,00
Ex Dividend Date-
Dividend Rate$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions1
Institutional Holdings Date2020-04-30
Institutional Bought Previous 3 Months-
Institutional Holdings Percent0,0%
Institutional Sold Previous 3 Months-
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0,0
Insider Sold Previous 3 Months-
Insider Shares Owned1 435 197 562
TRADING INFO
52 Week High$ 11,00
52 Week Low$ 2,25
52 Week High Change$ -67,33
21 Day Moving Average$ 3,3038
21 Day Extended Moving Average$ 3,3254
50 Day Moving Average$ 4,4608
50 Day Extended Moving Average$ 4,4395
200 Day Moving Average$ 6,8302
200 Day Extended Moving Average$ 6,622
10 Day Average Volume220
20 Day Average Volume308
30 Day Average Volume503
50 Day Average Volume1 501
Alpha0.000273
Beta1.088127
Standard Deviation0.342568
R20.016732
7 Day Price Change$ -0,06
7 Day Percent Change-2,0%
21 Day Price Change$ -0,66
21 Day Percent Change-18,33%
30 Day Price Change$ -1,01
30 Day Percent Change-25,57%
Month to Date Price Change$ -1,06
Month to Date Percent Change-26,5%
Quarter to Date Price Change$ -6,06
Quarter to Date Percent Change-67,33%
180 Day Price Change$ -2,06
180 Day Percent Change-41,2%
200 Day Price Change$ -3,06
200 Day Percent Change-51,0%
Year to Date Price Change$ -2,06
Year to Date Percent Change-41,2%

Acerus Pharmaceuticals Corporation (ASP) Key Ratios

PROFITABILITY
EBIT Margin-959,2%
EBITDA Margin-940,9%
Pre-Tax Profit Margin-858,1%
Profit Margin Count0,0%
Gross Margin55,9%
Profit Margin TOT0,0%
INCOME STATEMENTS
Revenue$ 3 311 646
Revenue Per Share$ 0,429652
Revenue (3 Years)$ 0,00
Revenue (5 Years)$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book-0,44
Total Debt To Equity2,61
Int Coverage-8,90
Current Ratio0,50
Leverage Ratio-1,30
Quick Ratio0,20
Long Term Debt To Capital0,68
VALUATION MEASURES
PE Ratio-1,00
Enterprise Value$ 63 625 383
Price to Sales6,8428
Price to Free Cash-0,70
PE High Last 5 Years7,70
Price To Book18,06
Price To Cash Flow595,00
PE Low Last 5 Years-2,20
Price to Tangible Book-0,44
MANAGEMENT EFFECTIVENESS
Receivables Turnover2,50
Invoice Turnover0,30
Assets Turnover0,10
Return Assets-93,76
Return on Equity415,09
Return on Capital-316,75

Acerus Pharmaceuticals Corporation (ASP) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers LLP
CEOEdward Gudaitis
Emplyoees14
Last AuditUE
CIK0001527246
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address7025 Langer Drive
Suite 205
Mississauga, ON L5N 0E8
Websitehttps://www.aceruspharma.com
Facsimile+1 905 569-1809
Telephone+1 289 326-5789
EmailIR@aceruspharma.com
Dernières Valeurs Consultées
TSX
ASP
Acerus Pha..
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

Les cours EURONEXT (CAC 40, etc. ) et FOREX (les devises) sont en direct si connecté.
NYSE, AMEX, et ASX sont en différé d'environ 20 minutes. Les autres cours sont en différé d'environ 15 minutes.

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V:fr D:20220629 12:24:09